Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Journal of Cellular Immunology|September 18, 2025
Modeling <i>TCIRG1</i> Neutropenia by Utilizing Patient Derived Induced Pluripotent Stem CellsVahagn Makaryan, Merideth L Kelley, Audrey Anna Bolyard, et al.Blood Advances|April 27, 2022
Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factorDavid C Dale, Audrey Anna Bolyard, James A Shannon, et al.Experimental Hematology|May 24, 2003
Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemiaAndrew A G Aprikyan, Tatyana Kutyavin, Steven Stein, et al.Cancer Medicine|April 8, 2014
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort studyEva Culakova, Ramya Thota, Marek S Poniewierski, et al.Blood|August 13, 2011
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndromeDavid C Dale, Audrey Anna Bolyard, Merideth L Kelley, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 24, 2017
A systematic literature review of the efficacy, effectiveness, and safety of filgrastimDavid C Dale, Jeffrey Crawford, Zandra Klippel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2008
Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor ProgramJohn P Miller, Elizabeth H Perry, Thomas H Price, et al.Cytokine|February 10, 2015
The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjectsNina Hastrup, Sauzanne Khalilieh, David C Dale, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Social and racial differences in selection of breast cancer adjuvant chemotherapy regimensJennifer J Griggs, Eva Culakova, Melony E S Sorbero, et al.Blood|February 7, 2004
Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cellsGöran Carlsson, Andrew A G Aprikyan, Ramin Tehranchi, et al.Pageof 12